FHIR Release 3 (STU) CI-Build

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0 . For a full list Continuous Integration Build of available versions, see FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationrequest0317

Example MedicationRequest/medrx0317 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Ballot Standards Status : Informative Compartments : Encounter , Group , Patient , Practitioner

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile MedicationRequest .

Generated Narrative with Details Narrative: MedicationRequest medrx0317

id identifier : medrx0317 http://www.bmc.nl/portal/prescriptions /12345689 (use: official, )

contained status : Completed

identifier intent : 12345689 (OFFICIAL) Order

Medications

- Reference
* Medication alemtuzumab 10 MG/ML [Lemtrada]

status subject : completed Donald Duck

intent authoredOn : order 2015-01-15

medication requester : id: med0303; Alemtuzumab 10mg/ml (Lemtrada) (Details : {RxNorm code '1594660' = '1594660', given as 'Alemtuzumab 10mg/ml (Lemtrada)'}) Patrick Pump

Reasons

- Concept
* Chronic lymphoid leukemia, disease (disorder)

dosageInstruction

subject step

component

text : Donald Duck Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

authoredOn timing : 15/01/2015 Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

Requesters DoseAndRates

- Agent Type OnBehalfOf Dose[x]
* Ordered 3 mg (Details: UCUM codemg = 'mg')

step

component

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- * Type Patrick Pump Dose[x]
* Organization/f002 Ordered 10 mg (Details: UCUM codemg = 'mg')

reasonCode step

component

text : Chronic Lymphoid Leukemia (disorder) (Details : {SNOMED CT code '92814006' = 'Chronic lymphoid leukemia', given as 'Chronic Lymphoid Leukemia (disorder)'}) Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

dosageInstruction timing : Duration 12weeks , , 3 per 1 week

  route : Intravenous route

Other examples that reference this example: method : Inject - dosing instruction imperative (qualifier value)

MedicationAdministration/IV Admin Not Given

DoseAndRates

MedicationDispense/IV Chemo
- Type Dose[x]
* Ordered 30 mg (Details: UCUM codemg = 'mg')

Generated Narrative: Medication #med0303

code : alemtuzumab 10 MG/ML [Lemtrada]

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.